Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Journal of Neuro-Oncology|August 4, 2005
Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomasLuisa Montanini, Caroline Regna-Gladin, Marica Eoli, et al.
Stem Cells (Dayton, Ohio)|September 13, 2017
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent TumorFrancesca Orzan, Francesca De Bacco, Giovanni Crisafulli, et al.
The Oncologist|November 24, 2025
Advances in the management of patients with IDH-mutant gliomaJessica Rossi, Alberto Picca, Orazio Santo Santonocito, et al.
Plos One|December 16, 2014
A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patientsPatrizia Mancuso, Angelica Calleri, Giuliana Gregato, et al.
Plos One|January 4, 2013
An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastomaSara Nava, Marta Dossena, Simona Pogliani, et al.
Acta Neuropathologica Communications|April 8, 2015
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial gliomaSerena Pellegatta, Lorella Valletta, Cristina Corbetta, et al.
The Oncologist|September 9, 2021
A Long-Term Extension Study of Bevacizumab in Patients With Solid TumorsAmit M Oza, François Dubois, Roberto Hegg, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2013
Operability of glioblastomas: "sins of action" versus "sins of non-action"Paolo Ferroli, Marco Schiariti, Gaetano Finocchiaro, et al.
Neuroimage. Clinical|July 22, 2026
Revisiting intensity normalization in brain [18F]FDG PET: What is reliable in autoimmune encephalitis?Fiene Marie Kuijper, Antoine Rogeau, Hélène Rostand, et al.
Oncotarget|July 27, 2013
FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migrationVéronique Frattini, Federica Pisati, Maria Carmela Speranza, et al.
Pageof 17